Consolidated Statement Of Comprehensive Income

CHUGAI PHARMACEUTICAL CO., LTD. - Filing #7541828

Concept 2023-01-01 to
2023-09-30
2023-01-01 to
2023-09-30
2023-07-01 to
2023-09-30
2023-01-01 to
2023-09-30
2023-01-01 to
2023-09-30
2023-01-01 to
2023-09-30
2023-01-01 to
2023-09-30
2022-07-01 to
2022-09-30
2022-01-01 to
2022-09-30
2022-01-01 to
2022-09-30
2022-01-01 to
2022-09-30
2022-01-01 to
2022-09-30
2022-01-01 to
2022-09-30
2022-01-01 to
2022-09-30
Consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
234,266,000,000 JPY
JPY
77,573,000,000 JPY
JPY
234,266,000,000 JPY
234,266,000,000 JPY
JPY
67,797,000,000 JPY
JPY
JPY
271,950,000,000 JPY
271,950,000,000 JPY
271,950,000,000 JPY
JPY
Other comprehensive income
Items that will not be reclassified to profit or loss
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income
-11,000,000 JPY
-158,000,000 JPY
-234,000,000 JPY
-293,000,000 JPY
Total of items that will not be reclassified to profit or loss
-11,000,000 JPY
-158,000,000 JPY
-234,000,000 JPY
-293,000,000 JPY
Items that may be reclassified to profit or loss
Exchange differences on translation of foreign operations
514,000,000 JPY
8,062,000,000 JPY
-237,000,000 JPY
6,632,000,000 JPY
Effective portion of cash flow hedges
9,305,000,000 JPY
-369,000,000 JPY
-3,607,000,000 JPY
-20,030,000,000 JPY
Total of items that may be reclassified to profit or loss
9,817,000,000 JPY
7,702,000,000 JPY
-3,851,000,000 JPY
-13,407,000,000 JPY
Other comprehensive income
9,806,000,000 JPY
7,544,000,000 JPY
-4,085,000,000 JPY
-13,700,000,000 JPY
Comprehensive income
241,810,000,000 JPY
7,544,000,000 JPY
87,379,000,000 JPY
JPY
234,266,000,000 JPY
241,810,000,000 JPY
JPY
63,712,000,000 JPY
JPY
-13,700,000,000 JPY
271,950,000,000 JPY
258,250,000,000 JPY
258,250,000,000 JPY
JPY
Comprehensive income attributable to
Owners of parent
87,379,000,000 JPY
241,810,000,000 JPY
63,712,000,000 JPY
258,250,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.